通合科技(300491.SZ):取得1項實用新型專利證書
格隆匯12月13日丨通合科技(300491.SZ)公佈,公司獲得中華人民共和國國家知識產權局頒發的實用新型專利證書1項,實用新型名稱為一種帶主動泄放保護功能的車載模塊測試系統。
本實用新型為公司自主研發,實現了模塊帶負載電機工作時,在負載突變的情況下對反饋的母線的電壓衝擊進行主動泄放的功能。泄放策略根據設置的最大電壓、最大電流允許值,實現脈衝泄放功能,當電壓低於閾值下限時停止泄放,在實現穩定母線電壓的同時,也保護了泄放電路進行安全工作。此外,該系統還具備母線電壓、電流實時數據採集和顯示功能,設備使用快速數據採集方式,具有響應及時、工作穩定的特點。本專利已經在公司生產經營中獲得應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.